Business
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
Solventum (NYSE: SOLV) today announced the consensus recommendations of an international, multidisciplinary panel of surgeons and wound care experts on the clinical use of closed incision negative pressure therapy (ciNPT) with reticulated open cell foam (ROCF) dressings.1 The updated recommendations, appearing in the International Wound Journal,2 underscore the evolution of ciNPT from a long-established adjunct to incision management into a therapy that can be applied in a variety of surgical pr
About this update from Solventum Corporation
[{"type":"text","content":"New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care","length":185,"tagName":"p","attribs":{}},{"type":"text","content":"Solventum™ Prevena™ Therapy is the only closed incision negative pressure therapy system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology","length":203,"tagName":"p","attribs":{}},{"type":"text","content":"ST. PAUL, Minn., Dec. 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced the consensus recommendations of an international, multidisciplinary panel of surgeons and wound care experts on the clinical use of closed incision negative pressure therapy (ciNPT) with reticulated open cell foam (ROCF) dressings.1 The updated recommendations, appearing in the International Wound Journal,2 underscore the evolution of ciNPT from a long-established adjunct to incision management into a therapy that can be applied in a variety of surgical procedures that directly align with healthcare professionals' global priorities around patient safety. Solventum Prevena™ Therapy is the only ciNPT that uses ROCF dressings, a proprietary design element unique to Prevena.","length":780,"tagName":"p"},{"type":"image","alt":"Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)","displaySize":"","headline":null,"caption":"Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/95d3b82885a66001cfb99d992f38785e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jB7DxrFrJMVlFTnHly7PFQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/95d3b82885a66001cfb99d992f38785e","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2369614/Solventum_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"ciNPT is used to manage and protect surgical incisions, particularly in patients at high risk of complications. It works by applying continuous negative pressure to the incision site, helping to remove fluid and reduce tension on the incision. A peer-reviewed meta-analysis of 84 studies across various surgical specialtie...